Rightslink® by Copyright Clearance Center

Results from a Phase 3, Multicenter, Non-Inferiority Study of Ravulizumab (ALXN1210) Versus Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Currently Treated with Eculizumab

Author:

Austin G. Kulasekararaj,Anita Hill,Scott T. Rottinghaus,Saskia Langemeijer,Richard A. Wells,F. Ataulfo Gonzalez-Fernandez,Anna Gaya,Jong-Wook Lee,Emilio Ojeda Gutierrez,Caroline I. Piatek,Jeffrey Szer,Antonio M. Risitano,Shinji Nakao,Eric Bachman et al.

Publication:

Blood

Publisher:

Elsevier

Date:

29 November 2018

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Creative Commons

This is an open access article distributed under the terms of the license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article.